Sunday, October 04, 2020 12:30:10 PM
Different types of monoclonal antibodies treat different types of diseases.
Just last week, a BOMBSHELL report came out from Gates Foundation affiliate "WELLCOME" called "Expanding Access to Monoclonal Antibody-Based Products: A Global Call to Action"
In a nutshell, MONOCLONAL ANTIBODY treatments are the FUTURE of medical care because they provide superior results without toxic side effects of Big Pharma's pharmaceuticals. They basically use your own body to heal itself organically without toxic side effects.
All sources, including the report and very interesting case studies can be found in this DD thread on Twitter. KNOW WHAT YOU HOLD! This is the future:
https://twitter.com/UncleBillyMoney/status/1312595840637300736?s=20
Dr. Cotropia is clearly a pioneer in monoclonal antibodies discovery dating back prior to 1989. He's been there from the beginning and now is his time as commercial access is finally being granted as Big Pharma is spread thin and can no longer fight the advancement of what President Trump called "miracle treatments sent down from God" just last night (10/3/20).
There are big issues at play here.
The efficacy and commercial viability of monoclonal antibodies has been known for some time but mass commercial use would have upset Big Pharma's profits because monoclonal antibodies treatments would have replaced some of their cash cow pharmaceuticals in their pipeline.
Note, BioClonetics is in late stages with HIV treatments but they also have several other treatments in the pipeline (see below). This could genuinely be the next Big Pharma, replacing antiquated special interests that do not always serve the health and needs of the people. Current Big Pharma views us as customers, rather than patients; monoclonal antibody treatments will usher in a new era and revolutionize medical care and there will be big winners in this space. $ENZC will be one of them. Get ready.
"BioClonetics is a company with proprietary technology for producing fully human monoclonal antibodies (mAbs) against infectious diseases including HIV, rabies, influenza A, influenza B, tetanus, and diphtheria. BioClonetics proprietary methodology for producing fully human MONOCLONAL ANTIBODIES may be used to produce therapeutic fully human MONOCLONAL ANTIBODIES for treating many infectious diseases including the #Coronavirus""
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM